A Study of LY2157299 in Healthy Participants

Completed · Phase 1

Conditions studied: Healthy Volunteers

In brief

Participants in this study will receive two oral doses of 150 milligram (mg) LY2157299 taken at least 4 days apart. One dose will be given without food. One dose will be given with a high fat meal. The study will evaluate the effect of a high fat meal on how much of the drug gets into the blood stream. Side effects will be documented. This study will last approximately 15 days not including screening. Screening is required within 30 days prior to the start of the study.

Key facts

Study ID

NCT01965808

Run by

Eli Lilly and Company

People needed

16

Starts

2013-10-01

Expected to finish

2013-12-01

Last updated by the study team

2013-12-04

Who can join

Age: 21 and older, up to 65. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Healthy sterile males or females
• Are able to eat a high fat meal
• No abnormal heart function or high blood pressure
• No participation in a clinical trial within 30 days
• No evidence of human deficiency virus (HIV), hepatitis C or hepatitis B

You may not qualify if…

• Have a clinically significant abnormality in the 12-lead electrocardiogram (ECG) that, in the opinion of the investigator, increases the risks associated with participating in the study

Where it is running

• For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. — Daytona Beach, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.